Linzess (linaclotide) is a prescription medication approved by the Food and Drug Administration (FDA) to treat certain types of constipation. Most Medicare Part D plans provide coverage for the drug ...

Linzess is a prescription medication for adults that treats irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). The typical dosage of Linzess for IBS-C is 290 ...

Trulance (plecanatide) and Linzess (linaclotide) are brand-name prescription medications. They’re approved by the Food and Drug Administration (FDA) to treat certain types of constipation. Trulance ...

Trulance and Linzess are prescription medications for adults that treat chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). They have similar safety and ...

What Is It, and Why Does It Matter? Linzess (linaclotide) is a prescription medicine that helps ease constipation caused by irritable bowel syndrome (IBS-C). It works by drawing more fluid into your ...

Ironwood Pharmaceuticals reaffirmed its 2026 financial guidance, including $1.125B–$1.175B in U.S. LINZESS sales, as it approaches a May 24 FDA decision on a pediatric indication. Q1 saw 97% year-over ...

Ironwood and AbbVie can now add “bloating” and “discomfort” to marketing for irritable bowel syndrome with constipation (IBS-C) drug Linzess, thanks to a supplemental NDA approval from the FDA Sept.

Linzess comes as an oral capsule. It belongs to a class of drugs called guanylate cyclase-C agonists. At this time, Linzess is only available in a brand-name form. There’s currently no generic version ...